FULC
NASDAQ · Pharmaceuticals
Fulcrum Therapeutics Inc
$3.89
+0.12 (+3.18%)
Open$3.83
Previous Close$3.77
Day High$3.91
Day Low$3.77
52W High$15.74
52W Low$2.83
Volume—
Avg Volume1.51M
Market Cap296.41M
P/E Ratio—
EPS$-0.90
SectorPharmaceuticals
Analyst Ratings
Strong Sell
12 analysts
Price Target
+1,364.8% upside
Current
$3.89
$3.89
Target
$56.98
$56.98
$37.54
$56.98 avg
$60.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 88.39M | 54.89M | 366.88M |
| Net Income | -10,744,616 | -6,005,188 | 47.13M |
| Profit Margin | -12.2% | -11.6% | 12.9% |
| EBITDA | -8,984,663 | -5,300,521 | 69.95M |
| Free Cash Flow | — | — | 54.75M |
| Rev Growth | +61.0% | +61.0% | +22.0% |
| Debt/Equity | — | — | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |